Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1963 1
1964 1
1971 1
2003 3
2004 1
2005 2
2006 1
2007 7
2008 6
2009 15
2010 20
2011 27
2012 29
2013 17
2014 19
2015 18
2016 16
2017 16
2018 12
2019 15
2020 20
2021 15
2022 21
2023 5
2024 14
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

265 results

Results by year

Filters applied: . Clear all
Page 1
Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement.
Eslam M, Alkhouri N, Vajro P, Baumann U, Weiss R, Socha P, Marcus C, Lee WS, Kelly D, Porta G, El-Guindi MA, Alisi A, Mann JP, Mouane N, Baur LA, Dhawan A, George J. Eslam M, et al. Among authors: alisi a. Lancet Gastroenterol Hepatol. 2021 Oct;6(10):864-873. doi: 10.1016/S2468-1253(21)00183-7. Epub 2021 Aug 6. Lancet Gastroenterol Hepatol. 2021. PMID: 34364544 Review.
NAFLD in children: new genes, new diagnostic modalities and new drugs.
Nobili V, Alisi A, Valenti L, Miele L, Feldstein AE, Alkhouri N. Nobili V, et al. Among authors: alisi a. Nat Rev Gastroenterol Hepatol. 2019 Sep;16(9):517-530. doi: 10.1038/s41575-019-0169-z. Epub 2019 Jul 5. Nat Rev Gastroenterol Hepatol. 2019. PMID: 31278377 Review.
An international multidisciplinary consensus on pediatric metabolic dysfunction-associated fatty liver disease.
Zhang L, El-Shabrawi M, Baur LA, Byrne CD, Targher G, Kehar M, Porta G, Lee WS, Lefere S, Turan S, Alisi A, Weiss R, Faienza MF, Ashraf A, Sundaram SS, Srivastava A, De Bruyne R, Kang Y, Bacopoulou F, Zhou YH, Darma A, Lupsor-Platon M, Hamaguchi M, Misra A, Méndez-Sánchez N, Ng NBH, Marcus C, Staiano AE, Waheed N, Alqahtani SA, Giannini C, Ocama P, Nguyen MH, Arias-Loste MT, Ahmed MR, Sebastiani G, Poovorawan Y, Al Mahtab M, Pericàs JM, Reverbel da Silveira T, Hegyi P, Azaz A, Isa HM, Lertudomphonwanit C, Farrag MI, Nugud AAA, Du HW, Qi KM, Mouane N, Cheng XR, Al Lawati T, Fagundes EDT, Ghazinyan H, Hadjipanayis A, Fan JG, Gimiga N, Kamal NM, Ștefănescu G, Hong L, Diaconescu S, Li M, George J, Zheng MH. Zhang L, et al. Among authors: alisi a. Med. 2024 Jul 12;5(7):797-815.e2. doi: 10.1016/j.medj.2024.03.017. Epub 2024 Apr 26. Med. 2024. PMID: 38677287
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores.
Bianco C, Jamialahmadi O, Pelusi S, Baselli G, Dongiovanni P, Zanoni I, Santoro L, Maier S, Liguori A, Meroni M, Borroni V, D'Ambrosio R, Spagnuolo R, Alisi A, Federico A, Bugianesi E, Petta S, Miele L, Vespasiani-Gentilucci U, Anstee QM, Stickel F, Hampe J, Fischer J, Berg T, Fracanzani AL, Soardo G, Reeves H, Prati D, Romeo S, Valenti L. Bianco C, et al. Among authors: alisi a. J Hepatol. 2021 Apr;74(4):775-782. doi: 10.1016/j.jhep.2020.11.024. Epub 2020 Nov 25. J Hepatol. 2021. PMID: 33248170 Free PMC article.
Artificial Intelligence and liver: Opportunities and barriers.
Balsano C, Burra P, Duvoux C, Alisi A, Piscaglia F, Gerussi A; Special Interest Group (SIG) Artificial Intelligence and Liver Disease; Italian Association for the Study of Liver (AISF). Balsano C, et al. Among authors: alisi a. Dig Liver Dis. 2023 Nov;55(11):1455-1461. doi: 10.1016/j.dld.2023.08.048. Epub 2023 Sep 16. Dig Liver Dis. 2023. PMID: 37718227 Free article. Review.
Pregnancy and Metabolic-Associated Fatty Liver Disease.
Mandato C, Panera N, Alisi A. Mandato C, et al. Among authors: alisi a. Endocrinol Metab Clin North Am. 2023 Sep;52(3):521-531. doi: 10.1016/j.ecl.2023.02.005. Epub 2023 Mar 22. Endocrinol Metab Clin North Am. 2023. PMID: 37495342 Review.
Epigenetic remodelling in human hepatocellular carcinoma.
Braghini MR, Lo Re O, Romito I, Fernandez-Barrena MG, Barbaro B, Pomella S, Rota R, Vinciguerra M, Avila MA, Alisi A. Braghini MR, et al. Among authors: alisi a. J Exp Clin Cancer Res. 2022 Mar 24;41(1):107. doi: 10.1186/s13046-022-02297-2. J Exp Clin Cancer Res. 2022. PMID: 35331312 Free PMC article. Review.
Global burden of disease attributable to metabolic risk factors in adolescents and young adults aged 15-39, 1990-2021.
Zhou XD, Chen QF, Targher G, Byrne CD, Mantzoros CS, Zhang H, Lonardo A, Lip GYH, Porta G, Misra A, Robertson AG, Luo F, Alisi A, Yang W, El-Shabrawi M, Al Momani H, Somers VK, Katsouras CS, Méndez-Sánchez N, Lefere S, Szepietowski O, Sung KC, Hui Ng NB, Valenti L, Lee WS, Pik-Shan Kong A, Kızılkaya MC, Ocama P, Ali A, Viveiros O, Ryan JD, Toro-Huamanchumo CJ, Perera N, Ataya K, Yen Kok KY, Gracia-Sancho J, Sharara AI, Prasad A, Oviedo RJ, Ospanov O, Ruiz-Úcar E, Alswat K, Abbas SI, Abdelbaki TN, Wong YJ, Fouad Y, Shapiro MD, Bacopoulou F, Sookoian S, Kehar M, Chan WK, Treeprasertsuk S, Adams L, Turan S, Zuluaga M, Pirola CJ, Thaher O, Molina GA, Jumaev NA, Al-Busafi SA, Opio CK, Lim-Loo MC, Adithya Lesmana CR, Kamani L, Zheng MH. Zhou XD, et al. Among authors: alisi a. Clin Nutr. 2024 Dec;43(12):391-404. doi: 10.1016/j.clnu.2024.11.016. Epub 2024 Nov 14. Clin Nutr. 2024. PMID: 39579593
265 results